Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine
Clinical trial NCT03284710 · COMPLETED
Trial details
- NCT number
- NCT03284710
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-19
- Primary completion
- 2019-12-12
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.